VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jun 5, 2017
Insider Transaction Report
Form 4
BOGER JOSHUA S
DirectorCEO
Transactions
- Disposition to Issuer
Common Stock
2017-06-01−2,941→ 281,147 total - Award
Common Stock
2017-06-01+2,188→ 284,088 total - Award
Stock Option (Right to Buy)
2017-06-01+5,295→ 5,295 totalExercise: $125.71Exp: 2027-05-31→ Common Stock (5,295 underlying) - Award
Deferred Stock Units
2017-06-01+2,941→ 2,941 total→ Common Stock (2,941 underlying)
Holdings
- 13,286(indirect: By 401(k))
Common Stock
- 64,525(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- [F2]Upon the vesting of restricted stock units granted to Dr. Boger on June 1, 2016, Dr. Boger deferred the receipt of 2,941 shares of common stock and received instead 2,941 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Dr. Boger is reporting the disposition of 2,941 shares of common stock in exchange for an equal number of deferred stock units.
- [F3]Fully vested.
- [F4]Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Boger's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Boger's disability or death.